PRA

Since the filing of the Schedule 13D on April 4, 2025, on June 26, 2026, the Issuer consummated the merger (the "Merger") pursuant to which each issued and outstanding Share was cancelled and converted into the right to receive $25.00 in cash, without interest. In connection with the Merger, the Reporting Persons' 2,615,966 Shares, which consisted of 896,690 Shares sold for the benefit of PRA Master Fund; 644,313 Shares sold for the benefit of Systematic Master Fund; 290,659 Shares sold for the benefit of the Relative Value Master Fund and 784,304 Shares sold for the benefit of two Managed Accounts, were cancelled and converted into the right to receive $25.00 in cash, without interest.

Since the filing of the Schedule 13D on April 4, 2025, on June 26, 2026, the Issuer consummated the merger (the "Merger") pursuant to which each issued and outstanding Share was cancelled and converted into the right to receive $25.00 in cash, without interest. In connection with the Merger, the Reporting Persons' 2,615,966 Shares, which consisted of 896,690 Shares sold for the benefit of PRA Master Fund; 644,313 Shares sold for the benefit of Systematic Master Fund; 290,659 Shares sold for the benefit of the Relative Value Master Fund and 784,304 Shares sold for the benefit of two Managed Accounts, were cancelled and converted into the right to receive $25.00 in cash, without interest.

Since the filing of the Schedule 13D on April 4, 2025, on June 26, 2026, the Issuer consummated the merger (the "Merger") pursuant to which each issued and outstanding Share was cancelled and converted into the right to receive $25.00 in cash, without interest. In connection with the Merger, the Reporting Persons' 2,615,966 Shares, which consisted of 896,690 Shares sold for the benefit of PRA Master Fund; 644,313 Shares sold for the benefit of Systematic Master Fund; 290,659 Shares sold for the benefit of the Relative Value Master Fund and 784,304 Shares sold for the benefit of two Managed Accounts, were cancelled and converted into the right to receive $25.00 in cash, without interest.

Since the filing of the Schedule 13D on April 4, 2025, on June 26, 2026, the Issuer consummated the merger (the "Merger") pursuant to which each issued and outstanding Share was cancelled and converted into the right to receive $25.00 in cash, without interest. In connection with the Merger, the Reporting Persons' 2,615,966 Shares, which consisted of 896,690 Shares sold for the benefit of PRA Master Fund; 644,313 Shares sold for the benefit of Systematic Master Fund; 290,659 Shares sold for the benefit of the Relative Value Master Fund and 784,304 Shares sold for the benefit of two Managed Accounts, were cancelled and converted into the right to receive $25.00 in cash, without interest.